Associated Papers
Clinical characteristics of SFTPC gene mutations in children: a single-center experience.
Yang T et al.
Italian Journal of Pediatrics, 2025
40890883 (PubMed )
Supplement: 13052_2025_2101_MOESM3_ESM.doc
A comparative analysis of clinical phenotypes and outcomes in childhood interstitial lung disease due to surfactant dysfunction disorders: focusing on mutations in SFTPC, ABCA3, and NKX2-1 genes.
Tang X et al.
Italian Journal of Pediatrics, 2025
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC.
Hosokawa M et al.
Iscience, 2023
Surfactant protein C dysfunction with new clinical insights for diffuse alveolar hemorrhage and autoimmunity.
Tang X et al.
Pediatric Investigation, 2019
A novel surfactant protein C gene mutation associated with progressive respiratory failure in infancy.
Litao MK et al.
Pediatric Pulmonology, 2017
Familial interstitial pneumonia in an adolescent boy with surfactant protein C gene (Y104H) mutation.
Kuse N et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of Wasog, 2013
C-terminal, endoplasmic reticulum-lumenal domain of prosurfactant protein C - structural features and membrane interactions.
Casals C et al.
The Febs Journal, 2008
A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation.
Mulugeta S et al.
American Journal of Respiratory Cell and Molecular Biology, 2005
Interstitial lung disease in children -- genetic background and associated phenotypes.
Hartl D et al.
Respiratory Research, 2005
Mutations in the surfactant protein C gene associated with interstitial lung disease.
Nogee LM et al.
Chest, 2002
Select a paper to view details